Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-16

Clinical Trial Update: Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo [NA]

View source ↗

Summary

The document reports a completed clinical trial evaluating gastrodin delivered by acupoint injection for sensorineural hearing loss with vertigo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gastrodin Acupoint Injection (gastrodin)

Snippet

Sponsor: The First Hospital of Hebei Medical University | Conditions: Sensorineural Hearing Loss, Vertigo | NA | Status: COMPLETED